Comparing DNA integration site clusters with scan statistics

Bioinformatics

Volumn 30, Issue 11, 2014, Pages 1493-1500

  Berry, Charles C ^a   Ocwieja, Karen E ^b   Malani, Nirav ^b   Bushman, Frederic D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; CHEMISTRY; COMPUTER PROGRAM; GENE VECTOR; GENETICS; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; JURKAT CELL LINE; STATISTICAL ANALYSIS; VIRUS DNA CELL DNA INTERACTION;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; DATA INTERPRETATION, STATISTICAL; DNA; GENETIC VECTORS; GENOMICS; HIV; HUMANS; JURKAT CELLS; SOFTWARE; VIRUS INTEGRATION;

EID: 84901294375     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu035     Document Type: Article

References (25)

1. Abel, U. et al. (2007) Real-time definition of non-randomness in the distribution of genomic events. PLoS One, 2, e570
2. Aldous, D. (1988) Probability Approximations via the Poisson Clumping Heuristic. Springer, New York
3. Alonso, J. et al. (2003) Genome-wide insertional mutagenesis of Arabidopsis thaliana. Science, 301, 653-657
4. Bickel, P.J. et al. (2010) Subsampling methods for genomic inference. Ann. Appl. Stat., 4, 1660-1697
5. Bourgon, R. et al. (2010) Independent filtering increases detection power for highthroughput experiments. In: Proceedings of the National Academy of Sciences. 9546
6. Craigie, R. and Bushman, F. (2012) HIV DNA integration. Cold Spring Harb. Perspect. Med., 2, a006890
7. Deichmann, A. et al. (2007) Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J. Clin. Invest., 117, 2225-2232
8. Gabriel, R. et al. (2009) Comprehensive genomic access to vector integration in clinical gene therapy. Nat. Med., 15, 1431-1436
9. Gentleman, R.C. et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol., 5, R80
10. Hacein-Bey-Abina, S. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med., 348, 255-256
11. Hacein-Bey-Abina, S. et al. (2010) Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med., 363, 355-364
12. Karlin, S. et al. (1991) Statistical methods and insights for protein and DNA sequences. Annu. Rev. Biophys. Biophys. Chem., 20, 175-203
13. Lander, E.S. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921. (Pubitemid 32165345
14. Lawrence, M. et al. (2013) Software for computing and annotating genomic ranges. PLoS Comput. Biol., 9, e1003118
15. Meyer, L.R. et al. (2013) The UCSC Genome Browser database: Extensions and updates 2013. Nucleic Acids Res., 41, D64-D69
16. Mitchell, R.S. et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol., 2, e234
17. Olshen, A.B. et al. (2004) Circular binary segmentation for the analysis of arraybased DNA copy number data. Biostatistics, 5, 557-572. (Pubitemid 41180205
18. Schroder, A.R.W. et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529. (Pubitemid 35232295
19. Schulz, K.F. et al. (2010) Consort 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Med., 8, 18
20. Siegmund, D. et al. (2011) False discovery rate for scanning statistics. Biometrika, 98, 979-985
21. U.S. Food and Drug Administration, CBER. (2006) Gene Therapy Clinical Trials Observing Subjects for Delayed Adverse Events. FDA:Maryland
22. Wang, G.P. et al. (2007) HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res., 17, 1186-1194
23. Wang, G.P. et al. (2008) DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res., 36, e49
24. Wu, X. et al. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749-1751. (Pubitemid 36712571
25. Zhang, Y. (2008) Poisson approximation for significance in genome-wide ChIP-chip tiling arrays. Bioinformatics, 24, 2825-2831